Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2022 is -12.50% vs -20.00% in Jun 2022
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2022 is 2.86% vs 55.13% in Jun 2022
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2022 is 48.15% vs 58.46% in Jun 2022
Interest
QoQ Growth in quarter ended Sep 2022 is 0.00% vs -66.67% in Jun 2022
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2022 has improved from Jun 2022
Compare Quarterly Results Of Statera Biopharma, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2022 is -12.50% vs -20.00% in Jun 2022
YoY Growth in quarter ended Sep 2022 is 250.00% vs 0.00% in Sep 2021
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2022 is 2.86% vs 55.13% in Jun 2022
YoY Growth in quarter ended Sep 2022 is 73.23% vs -1,487.50% in Sep 2021
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2022 is 48.15% vs 58.46% in Jun 2022
YoY Growth in quarter ended Sep 2022 is 85.26% vs -1,087.50% in Sep 2021
Quarterly - Interest
QoQ Growth in quarter ended Sep 2022 is 0.00% vs -66.67% in Jun 2022
YoY Growth in quarter ended Sep 2022 is 0.00% vs 0.00% in Sep 2021
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2022 has improved from Jun 2022
YoY Growth in quarter ended Sep 2022 has improved from Sep 2021






